Sajjan Daniel

Sajjan is a Drug Safety Physician with over 15 plus years in the pharmaceutical industry, who has experience in drug safety/pharmacovigilance, strategic PV & risk planning, clinical research, regulatory affairs, FDA & EMEA/MHRA/AFSSAPS interactions, ICH, compliance, training, risk management, drug safety crisis management & electronic data capture. During my tenure as a pharmaceutical physician, build safety organizations considered among the best in the industry, in addition to putting the necessary organization, procedures and system in place for ensuring compliance with global regulatory requirements and who has extensive experience managing important product safety issues from medical and regulatory perspective.
He has Demonstrated success in providing expertise for regulatory, study design, protocol, standard operating procedures (SOPs), risk management (pharmacosurveillance), data analysis, and submissions of INDs, NDAs, ANDAs to the FDA for approval. His Previous research experience in fields such as Pharmacology, Oncology, Neurology and Cardiology.